Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis

April 2017 | | ID: GFBEC843CFBEN
Renub Research

Abstracts

Global Influenza Vaccine Market is worth more than US$ 5 Billion. Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza Vaccinated Population will increase in forecast period.

United States has the highest market share in Influenza Vaccine Market. United States Influenza Vaccine Market Share was almost 4 times more than China and Japan Influenza Vaccine Market Share. United States & China together captures close to 60 percent in Pediatrics Influenza Vaccine Market Share. Whereas, in adult vaccination segments, United States and Japan will share more than 50 percent market share by 2022.

Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis is the 8th report by Renub Research on Influenza Vaccine Market. This is a 383 page report with 386 Figures and 7 Tables provides data of 30 countries globally on Influenza Vaccine Market. The report provides data on Pediatrics and Adult Influenza Vaccinated Population Numbers and Market. All 30 Countries have been extensively studied from 2 major points, which has been further sub-divided into 2 more points:

1. Influenza Vaccine Market & Forecast (2011 – 2022)
  a. Pediatrics Influenza Vaccine Market & Forecast
  b. Adult Influenza Vaccine Market & Forecast
2. Influenza Vaccinated Population & Forecast (2011 – 2022)
  a. Pediatrics Influenza Vaccinated Population & Forecast
  b. Adult Influenza Vaccinated Population & Forecast

30 Countries Influenza Vaccine Market covered in the report are as follows

1. United States
2. Netherlands
3. Denmark
4. Estonia
5. Finland
6. Germany
7. France
8. Hungary
9. Iceland
10. Ireland
11. Italy
12. Latvia
13. Lithuania
14. Luxembourg
15. Malta
16. Norway
17. Poland
18. Portugal
19. Romania
20. Slovakia
21. Slovenia
22. Spain
23. Sweden
24. United Kingdom
25. China
26. India
27. Brazil
28. Japan
29. Australia
30. New Zealand

This report offers the best viewpoint on the leading five influenza vaccine brands

1. Vaxigrip/Fluzone
2. Fluarix/Flulaval
3. FluMist/Fluenz
4. Afluria/Fluvax and Fluvirin/Flucelvax
5. Anflu

Scope of Study

• Influenza Vaccine Market has been divided into two segments Pediatrics Influenza Vaccine Market and Adult Influenza Vaccine Market.
• Influenza Vaccine Market share & Forecast, Pediatrics Influenza Vaccine Market share & Forecast and Adult Influenza Vaccine Market share & Forecast.
• Influenza Vaccinated Population & Forecast has been divided into two segments Pediatrics Influenza Vaccinated Population & Forecast and Adult Influenza Vaccinated Population & Forecast.
• Influenza Vaccine Brand Sales and Forecast

This report is a combination of 6 reports

1. Europe Influenza Vaccine Market & Forecast (23 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis
2. Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast
3. Influenza Vaccine Market & Forecast in (West Europe) Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult)
4. Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination
5. Seasonal Influenza Vaccination Market in Hungary, Romania, Slovakia and Slovenia (East Europe) By (Infant & Adult) Forecast
6. Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast

Contents

1. EXECUTIVE SUMMARY

2. INFLUENZA – INTRODUCTION

2.1 Different Types of Influenza Viruses
  2.1.1 Type A Flu Virus
  2.1.2 Type B Flu Virus
  2.1.3 Type C Flu Virus
  2.1.4 Type D Flu Virus
2.2 An Influenza Pandemic

3. STRUCTURE OF INFLUENZA VIRUS

4. NOTABLE INFLUENZA PANDEMICS

5. WORLDWIDE INFLUENZA VACCINATED POPULATION

5.1 Worldwide Seasonal Influenza Vaccinated Child Population
5.2 Worldwide Seasonal Influenza Vaccinated Adult Population

6. WORLDWIDE SEASONAL INFLUENZA VACCINE MARKET

6.1 Worldwide - Seasonal Influenza Child Vaccine Market
6.2 Worldwide Seasonal Influenza Adult Vaccine Market

7. WORLDWIDE SEASONAL INFLUENZA VACCINE MARKET SHARE ANALYSIS

7.1 Worldwide Seasonal Influenza Vaccine Market Share
7.2 Worldwide Seasonal Influenza Child Vaccine Market Share
7.3 Worldwide Seasonal Influenza Adult Vaccine Market Share

8. UNITED STATES

8.1 United States Seasonal Influenza Vaccinated Total Population
  8.1.1 United States Seasonal Influenza Vaccinated Child Population
  8.1.2 United States Seasonal Influenza Vaccinated Adult Population
8.2 United States Seasonal Influenza Vaccine Market
  8.2.1 United States Seasonal Influenza Child Vaccine Market
  8.2.2 United States Seasonal Influenza Adult Vaccine Market

9. NETHERLANDS

9.1 Netherlands Seasonal Influenza Vaccinated Total Population
  9.1.1 Netherlands Seasonal Influenza Vaccinated Child Population
  9.1.2 Netherlands Seasonal Influenza Vaccinated Adult Population
9.2 Netherlands Seasonal Influenza Vaccine Market
  9.2.1 Netherlands Seasonal Influenza Child Vaccine Market
  9.2.2 Netherlands Seasonal Influenza Adult Vaccine Market

10. DENMARK

10.1 Denmark Seasonal Influenza Vaccinated Total Population
  10.1.1 Denmark Seasonal Influenza Vaccinated Child Population
  10.1.2 Denmark Seasonal Influenza Vaccinated Adult Population
10.2 Denmark Seasonal Influenza Vaccine Market
  10.2.1 Denmark Seasonal Influenza Child Vaccine Market
  10.2.2 Denmark Seasonal Influenza Adult Vaccine Market

11. ESTONIA

11.1 Estonia Seasonal Influenza Vaccinated Total Population
  11.1.1 Estonia Seasonal Influenza Vaccinated Child Population
  11.1.2 Estonia Seasonal Influenza Vaccinated Adult Population
11.2 Estonia Seasonal Influenza Vaccine Market
  11.2.1 Estonia Seasonal Influenza Child Vaccine Market
  11.2.2 Estonia Seasonal Influenza Adult Vaccine Market

12. FINLAND

12.1 Finland Seasonal Influenza Vaccinated Total Population
  12.1.1 Finland Seasonal Influenza Vaccinated Child Population
  12.1.2 Finland Seasonal Influenza Vaccinated Adult Population
12.2 Finland Seasonal Influenza Vaccine Market
  12.2.1 Finland Seasonal Influenza Child Vaccine Market
  12.2.2 Finland Seasonal Influenza Adult Vaccine Market

13. GERMANY

13.1 Germany Seasonal Influenza Vaccinated Total Population
  13.1.1 Germany Seasonal Influenza Vaccinated Child Population
  13.1.2 Germany Seasonal Influenza Vaccinated Adult Population
13.2 Germany Seasonal Influenza Vaccine Market
  13.2.1 Germany Seasonal Influenza Child Vaccine Market
  13.2.2 Germany Seasonal Influenza Adult Vaccine Market

14. FRANCE

14.1 France Seasonal Influenza Vaccinated Total Population
  14.1.1 France Seasonal Influenza Vaccinated Child Population
  14.1.2 France Seasonal Influenza Vaccinated Adult Population
14.2 France Seasonal Influenza Vaccine Market Analysis
  14.2.1 France Seasonal Influenza Child Vaccine Market
  14.2.2 France Seasonal Influenza Adult Vaccine Market

15. HUNGARY

15.1 Hungary Seasonal Influenza Vaccinated Total Population
  15.1.1 Hungary Seasonal Influenza Vaccinated Child Population
  15.1.2 Hungary Seasonal Influenza Vaccinated Adult Population
15.2 Hungary Seasonal Influenza Vaccine Market
  15.2.1 Hungary Seasonal Influenza Child Vaccine Market
  15.2.2 Hungary Seasonal Influenza Adult Vaccine Market

16. ICELAND

16.1 Iceland Seasonal Influenza Vaccinated Total Population
  16.1.1 Iceland Seasonal Influenza Vaccinated Child Population
  16.1.2 Iceland Seasonal Influenza Vaccinated Adult Population
16.2 Iceland Seasonal Influenza Vaccine Market
  16.2.1 Iceland Seasonal Influenza Child Vaccine Market
  16.2.2 Iceland Seasonal Influenza Adult Vaccine Market

17. IRELAND

17.1 Ireland Seasonal Influenza Vaccinated Total Population
  17.1.1 Ireland Seasonal Influenza Vaccinated Child Population
  17.1.2 Ireland Seasonal Influenza Vaccinated Adult Population
17.2 Ireland Seasonal Influenza Vaccine Market
  17.2.1 Ireland Seasonal Influenza Child Vaccine Market
  17.2.2 Ireland Seasonal Influenza Adult Vaccine Market

18. ITALY

18.1 Italy Seasonal Influenza Vaccinated Total Population
  18.1.1 Italy Seasonal Influenza Vaccinated Child Population
  18.1.2 Italy Seasonal Influenza Vaccinated Adult Population
18.2 Italy Seasonal Influenza Vaccine Market
  18.2.1 Italy Seasonal Influenza Child Vaccine Market
  18.2.2 Italy Seasonal Influenza Adult Vaccine Market

19. LATVIA

19.1 Latvia Seasonal Influenza Vaccinated Total Population
  19.1.1 Latvia Seasonal Influenza Vaccinated Child Population
  19.1.2 Latvia Seasonal Influenza Vaccinated Adult Population
19.2 Latvia Seasonal Influenza Vaccine Market
  19.2.1 Latvia Seasonal Influenza Child Vaccine Market
  19.2.2 Latvia Seasonal Influenza Adult Vaccine Market

20. LITHUANIA

20.1 Lithuania Seasonal Influenza Vaccinated Total Population
  20.1.1 Lithuania Seasonal Influenza Vaccinated Child Population
  20.1.2 Lithuania Seasonal Influenza Vaccinated Adult Population
20.2 Lithuania Seasonal Influenza Vaccine Market
  20.2.1 Lithuania Seasonal Influenza Child Vaccine Market
  20.2.2 Lithuania Seasonal Influenza Adult Vaccine Market

21. LUXEMBOURG

21.1 Luxembourg Seasonal Influenza Vaccinated Total Population
  21.1.1 Luxembourg Seasonal Influenza Vaccinated Child Population
  21.1.2 Luxembourg Seasonal Influenza Vaccinated Adult Population
21.2 Luxembourg Seasonal Influenza Vaccine Market
  21.2.1 Luxembourg Seasonal Influenza Child Vaccine Market
  21.2.2 Luxembourg Seasonal Influenza Adult Vaccine Market

22. MALTA

22.1 Malta Seasonal Influenza Vaccinated Total Population
  22.1.1 Malta Seasonal Influenza Vaccinated Child Population
  22.1.2 Malta Seasonal Influenza Vaccinated Adult Population
22.2 Malta Seasonal Influenza Vaccine Market
  22.2.1 Malta Seasonal Influenza Child Vaccine Market
  22.2.2 Malta Seasonal Influenza Adult Vaccine Market

23. NORWAY

23.1 Norway Seasonal Influenza Vaccinated Total Population
  23.1.1 Norway Seasonal Influenza Vaccinated Child Population
  23.1.2 Norway Seasonal Influenza Vaccinated Adult Population
23.2 Norway Seasonal Influenza Vaccine Market
  23.2.1 Norway Seasonal Influenza Child Vaccine Market
  23.2.2 Norway Seasonal Influenza Adult Vaccine Market

24. POLAND

24.1 Poland Seasonal Influenza Vaccinated Total Population
  24.1.1 Poland Seasonal Influenza Vaccinated Child Population
  24.1.2 Poland Seasonal Influenza Vaccinated Adult Population
24.2 Poland Seasonal Influenza Vaccine Market
  24.2.1 Poland Seasonal Influenza Child Vaccine Market
  24.2.2 Poland Seasonal Influenza Adult Vaccine Market

25. PORTUGAL

25.1 Portugal Seasonal Influenza Vaccinated Total Population
  25.1.1 Portugal Seasonal Influenza Vaccinated Child Population
  25.1.2 Portugal Seasonal Influenza Vaccinated Adult Population
25.2 Portugal Seasonal Influenza Vaccine Market
  25.2.1 Portugal Seasonal Influenza Child Vaccine Market
  25.2.2 Portugal Seasonal Influenza Adult Vaccine Market

26. ROMANIA

26.1 Romania Seasonal Influenza Vaccinated Total Population
  26.1.1 Romania Seasonal Influenza Vaccinated Child Population
  26.1.2 Romania Seasonal Influenza Vaccinated Adult Population
26.2 Romania Seasonal Influenza Vaccine Market
  26.2.1 Romania Seasonal Influenza Child Vaccine Market
  26.2.2 Romania Seasonal Influenza Adult Vaccine Market

27. SLOVAKIA

27.1 Slovakia Seasonal Influenza Vaccinated Total Population
  27.1.1 Slovakia Seasonal Influenza Vaccinated Child Population
  27.1.2 Slovakia Seasonal Influenza Vaccinated Adult Population
27.2 Slovakia Seasonal Influenza Vaccine Market
  27.2.1 Slovakia Seasonal Influenza Child Vaccine Market
  27.2.2 Slovakia Seasonal Influenza Adult Vaccine Market

28. SLOVENIA

28.1 Slovenia Seasonal Influenza Vaccinated Total Population
  28.1.1 Slovenia Seasonal Influenza Vaccinated Child Population
  28.1.2 Slovenia Seasonal Influenza Vaccinated Adult Population
28.2 Slovenia Seasonal Influenza Vaccine Market
  28.2.1 Slovenia Seasonal Influenza Child Vaccine Market
  28.2.2 Slovenia Seasonal Influenza Adult Vaccine Market

29. SPAIN

29.1 Spain Seasonal Influenza Vaccinated Total Population
  29.1.1 Spain Seasonal Influenza Vaccinated Child Population
  29.1.2 Spain Seasonal Influenza Vaccinated Adult Population
29.2 Spain Seasonal Influenza Vaccine Market
  29.2.1 Spain Seasonal Influenza Child Vaccine Market
  29.2.2 Spain Seasonal Influenza Adult Vaccine Market

30. SWEDEN

30.1 Sweden Seasonal Influenza Vaccinated Total Population
  30.1.1 Sweden Seasonal Influenza Vaccinated Child Population
  30.1.2 Sweden Seasonal Influenza Vaccinated Adult Population
30.2 Sweden Seasonal Influenza Vaccine Market
  30.2.1 Sweden Seasonal Influenza Child Vaccine Market
  30.2.2 Sweden Seasonal Influenza Adult Vaccine Market

31. UNITED KINGDOM

31.1 United Kingdom Seasonal Influenza Vaccinated Total Population
  31.1.1 United Kingdom Seasonal Influenza Vaccinated Child Population
  31.1.2 United Kingdom Seasonal Influenza Vaccinated Adult Population
31.2 United Kingdom Seasonal Influenza Vaccine Market
  31.2.1 United Kingdom Seasonal Influenza Child Vaccine Market
  31.2.2 United Kingdom Seasonal Influenza Adult Vaccine Market

32. CHINA

32.1 China Seasonal Influenza Vaccinated Total Population
  32.1.1 China Seasonal Influenza Vaccinated Child Population
  32.1.2 China Seasonal Influenza Vaccinated Adult Population
32.2 China Seasonal Influenza Vaccine Market
  32.2.1 China Seasonal Influenza Child Vaccine Market
  32.2.2 China Seasonal Influenza Adult Vaccine Market

33. INDIA

33.1 India Seasonal Influenza Vaccinated Total Population
  33.1.1 India Seasonal Influenza Vaccinated Child Population
  33.1.2 India Seasonal Influenza Vaccinated Adult Population
33.2 India Seasonal Influenza Vaccine Market
  33.2.1 India Seasonal Influenza Child Vaccine Market
  33.2.2 India Seasonal Influenza Adult Vaccine Market

34. BRAZIL

34.1 Brazil Seasonal Influenza Vaccinated Total Population
  34.1.1 Brazil Seasonal Influenza Vaccinated Child Population
  34.1.2 Brazil Seasonal Influenza Vaccinated Adult Population
34.2 Brazil Seasonal Influenza Vaccine Market
  34.2.1 Brazil Seasonal Influenza Child Vaccine Market
  34.2.2 Brazil Seasonal Influenza Adult Vaccine Market

35. JAPAN

35.1 Japan Seasonal Influenza Vaccinated Total Population
  35.1.1 Japan Seasonal Influenza Vaccinated Child Population
  35.1.2 Japan Seasonal Influenza Vaccinated Adult Population
35.2 Japan Seasonal Influenza Vaccine Market
  35.2.1 Japan Seasonal Influenza Child Vaccine Market
  35.2.2 Japan Seasonal Influenza Adult Vaccine Market

36. AUSTRALIA

36.1 Australia Seasonal Influenza Vaccinated Total Population
  36.1.1 Australia Seasonal Influenza Vaccinated Child Population
  36.1.2 Australia Seasonal Influenza Vaccinated Adult Population
36.2 Australia Seasonal Influenza Vaccine Market
  36.2.1 Australia Seasonal Influenza Child Vaccine Market
  36.2.2 Australia Seasonal Influenza Adult Vaccine Market

37. NEW ZEALAND

37.1 New Zealand Seasonal Influenza Vaccinated Total Population
  37.1.1 New Zealand Seasonal Influenza Vaccinated Child Population
  37.1.2 New Zealand Seasonal Influenza Vaccinated Adult Population
37.2 New Zealand Seasonal Influenza Vaccine Market
  37.2.1 New Zealand Seasonal Influenza Child Vaccine Market
  37.2.2 New Zealand Seasonal Influenza Adult Vaccine Market

38. WORLDWIDE – SEASONAL INFLUENZA VACCINE BRAND SALES AND FORECAST

38.1 Vaxigrip/Fluzone Vaccine Sales and Forecast
38.2 Fluarix/Flulaval Vaccine Sales and Forecast
38.3 FluMist/Fluenz Vaccine Sales and Forecast
38.4 Afluria/Fluvax and Fluvirin/Flucelvax Vaccine Sales and Forecast
38.5 Anflu Vaccine Sales and Forecast

39. SEASONAL INFLUENZA VACCINE – GROWTH DRIVERS

39.1 Growing Awareness on Seasonal Influenza Vaccination
39.2 Vaccine Companies Plan to Augment Flu Vaccine Production
39.3 Increased Engagement by the Governments

40. SEASONAL INFLUENZA VACCINE – CHALLENGES

40.1 Regulatory Issues with Novel Influenza Vaccines
40.2 Lack of Healthcare Infrastructure
40.3 Limited Reimbursement and Access to the Vaccines
40.4 China Tightens Rules on Vaccine Distribution